Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01680887 · ClinicalTrials.gov registry record · Phase 2
A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 156
- Enrollment target
NCT01680887: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT01680887 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 156 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01680887, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 156 participants
- Enrollment target
Study Summary
This is a double-blind placebo-controlled clinical trial (n = 156) of varenicline for the treatment of cocaine dependence that utilizes contingency management to promote treatment attendance.
Interventions
- DRUG Placebo
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2012-08 |
| Est. Completion | 2019-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01680887
The ClinicalTrials.gov registry entry for NCT01680887 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01680887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01680887 about?
NCT01680887 is a clinical study titled "A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence". This is a double-blind placebo-controlled clinical trial (n = 156) of varenicline for the treatment of cocaine dependence that utilizes contingency management to promote treatment attendance.
What is the current status of trial NCT01680887?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 156 participants. The study started on 2012-08. Estimated completion is 2019-06.
What interventions are being tested in trial NCT01680887?
The interventions under investigation include: Placebo (DRUG), Varenicline (DRUG).
Who is sponsoring clinical trial NCT01680887?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.